6th BIENNIAL SCIENTIFIC SESSION OF THE NORTH AMERICAN CHAPTER OF THE ISSVD.
December 7 & 8, 2018 . *Montreal, QC, Canada . SUBMISSION DEADLINE
: September 7, 2018 EXTENDED: October 30, 2018
- No Abstracts without final data will be accepted.
- You must be a member of the North American Chapter in order to present an abstract.
- Content of the abstract cannot have been previously published.
Authors Formatting: (please bold the presenting author)
CK Piper, LMSW1,2, L Legocki, PhD3, B Reed, MD3, M Moravek, MD4, K Lavin, BA2, K Wade, PhD2, K Musolf, MD3, HK Haefner, MD4 .
1Center for Vulvar Diseases, 2Department of Social Work, 3Department of Family Medicine, 4Department of Obstetrics and Gynecology; University of Michigan Health Systems, Ann Arbor,MI, USA.
The abstract should be 250 words or less and contain 4 paragraphs with the following headings:
(1) Objective: stating the hypothesis of the study;
(2) Methods: including the means for problem solving, the subjects (number and relevant characteristics), the intervention studied, and a brief statistical analysis;
(3) Results: including the outcome of the study and statistical significance; and
(4) Conclusions: stating the outcome importance.
Write abstracts in the active voice. Express ideas briefly, clearly, and concisely. -Use only standard abbreviations. Spell out all abbreviations in full preceding their first usage in the text. -For drugs, devices, or patented procedures, state the generic or common name, followed in parentheses by the trade name (optional), city, and country of manufacture. Abstracts are not necessary for editorials, commentaries, correspondence, home study courses, opinion pieces, book reviews, and abstracts from meetings.
Presentation times are strictly limited so presenters should not spend too much time on introductory material unless it is highly technical. Oral and poster presentations are considered of equal importance and the final format will be determined by the Scientific Program Committee.
The ISSVD is dedicated to improving communication about vulvar diseases. The use of ISSVD-approved terminology, therefore, is critical to the understanding of a presenter’s topic.
Presenters should review the pertinent current literature on his or her subject, as abstracts with incorrect terminology will not be accepted.
CURRENT ISSVD TERMINOLOGY AND CLASSIFICATION OF VULVAR DISEASES*
Manuscripts may be submitted directly to the Journal of Lower Genital Tract Disease following the presentation via their submission website: http://www.editorialmanager.com/jlgtd/default.aspx